Control of a school outbreak of meningococcal B infection through chemoprophylaxis with azithromycin and ciprofloxacin;Control de un brote escolar de enfermedad meningocócica serogrupo B mediante quimioprofilaxis con azitromicina y ciprofloxacino

Anales Espanoles de Pediatria

Volumn 53, Issue 5, 2000, Pages 412-417

  Gonzalez De Aledo Linos A ^a,b   Garcia Merino J ^a  

^a Dir General de Sanidad de Cantabria   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CIPROFLOXACIN;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; COMPARATIVE STUDY; EPIDEMIC; FEMALE; HUMAN; MALE; MENINGOCOCCOSIS; MIDDLE AGED; PRESCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; SEX FACTORS;

EID: 0034330405     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Girgis N, Sultan Y, Frenck RW, El-Gendy A, Farid Z, Mateczun A. Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria Meningitidis Pediatr Infect Dis J 1998; 17: 816-819
2. American Academy of Pediatrics. Meningococcal disease prevention and control strategies for practice-based physicians. Pediatrics 1996; 97: 404-411.
3. Comité Asesor de vacunas de la Asociación Española de Pediatría. Manual de vacunas en Pediatría. Asociación Española de Pediatría, 1996.
4. González de Aledo Linos A, García Merino J. Seroprevalencia de anticuerpos bactericidas frente al Meningococo C en Cantabria 10 meses después de la campaña de vacunación. Rev Esp Salud Pública 1998; 72: 365-374
5. González de Aledo Linos A, García Merino J. Efectos de la vacuna de la enfermedad meningocócica en Cantabria. Rev Esp Salud Pública 1998; 72: 415-418
6. González de Aledo Linos A, García Merino J. Evolución epidemiológica de la meningitis C y finalización de la campaña de vacunación. Bol Epidemiol Cantabria 1999; 3: 1-4.
7. Dirección General de Prevención y Promoción de la Salud. Protocolo de actuación ante las meningitis. Comunidad de Madrid, 1993.
8. Centers For Disease Control And Prevention. Control and prevention of meningococcal disease and Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46 (No. RR-5): 1-21.
9. a ed. Buenos Aires: Médica Panamericana, 1999; 389-394.
10. Bitar CN, Steele RW. Use of prophylactic antibiotics in children. En: Adv Pediatr Infect Dis, eds. Mosby 1995; 10: 227-245
11. Advisory Committee on Epidemiology. Guidelines for control of meningococcal disease Can Dis Weekly Rep 1991; 17: 245-249.
12. Riedo FX, Plikaytis BD, Broome CV. Epidemiology and prevention of meningococcal disease. Pediatr Infect Dis J 1995; 14: 643-657.
13. PHLS Meningococcal Infections Working Parry. The epidemiology and control of meningococcal disease. Communicable Disease Report 1989; 8: 3-6.
14. Mayon-White RT, Heath PT. Preventive strategies on meningococcal disease. Arch Dis Child 1997; 75: 178-181.
15. Rockowitz J, Tunkel AR. Bacterial meningitis, practical guidelines for management. Drugs 1995; 50: 838-853.
16. Schwartz B, Al-Ruwais A, A'Ashi J, Broome CV, Al-Tobaiqi A, Fontaine RE et al Comparación de la eficacia de la ceftriaxona y la rifampicina en la erradicación del estado de portador faríngeo de Neisseria meningitidis grupo A. Lancet (ed.esp) 1988; 1: 1239-1242.
17. Gilja OH, Halstensen A, Digranes A, Mylvaganam H, Aksnes A, Hoiby EA Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis. Antimicrob Agents Chemoter 1993, 37: 2024-2026.
18. Jaruratanasirikul S, Hortiwakul R, Tantisarasart T, Phuenpathom N, Tussanasunthornwong S. Distribution of Azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye Antimicrob Agents Chemoter 1996; 40 825-826.
19. Anónimo. Meningitis meningocócica: puesta al día. Bol Ter Andaluz 1998; 14: 1-4.
20. Camp KA, Miyagi SL, Schroeder DJ. Potential quinolone-induced cartilage toxicity in children. Ann Pharmacother 1994; 28: 336-338.
21. Warren RW. Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones. Pediatr Infect Dis J 1997, 16: 118-122.
22. Schaad UB, Wedgwood J, Ruedeberg A, Kraemer R, Hampel B. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis. Pediatr Infect Dis J 1997; 16: 106-111.
23. Redmond A, Sweeney L, MacFarland M, Mitchell M, Daggett S, Kubin R. Oral ciprofloxacin in the treatment of pseudomonas exacerbations of pediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning. J Int Med Res 1998; 26: 304-312.
24. Naccari F, Salpietro DC, De Sarro A, Masaracchio A, Barbieri I. Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI). Res Commun Mol Pathol Pharmacol 1998; 99: 187-192.
25. Green S, Tillotson G. Use of Ciprofloxacin in developing countries Pediatr Infect Dis J 1997; 16: 150-159. (discussion 160-162)
26. Schaad UB, Salam MA, Aujard Y, Dagan R, Green SDR, Peltola H et al. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy Commission. Pediatr Infect Dis J 1995; 14: 1-9
27. Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KV et al. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 1999; 86: 126-134
28. Freifeld A, Pizzo P. Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients. Pediatr Infect Dis J 1997; 16: 140-145.
29. Salam MA, Dhar U, Khan WA, Bennish ML. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Lancet 1998; 352: 522-527.
30. Thomsen LL Paerregaard A. Treatment with ciprofloxacin in children with typhoid fever. Scand J Infect Dis 1998; 30: 355-357.
31. Heggers JP, Villarreal C, Edgar P, Wolf S, Klein GL, John SD et al. Ciprofloxacin as a therapeutic modality in pediatric burn wound infections: efficacious or contraindicated? Arch Surg 1998; 133: 1247-1250.
32. Cuevas LE, Kazembe P, Mughogho GK, Tillotson GS, Hart CA. Eradication of nasopharyngeal carriage of Neisseria Meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampin. J Infect Dis 1995; 171: 728-731
33. Shehab S, Keller N, Barkay A, Leitner L, Leventhal A, Block C. Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israel village Eur J Microbiol Infect Dis 1998; 17: 749-753